Genmab A (GMAB) Debt Ratio (2022 - 2026)
Genmab A's (GMAB) quarterly Debt Ratio came in at 0.41 in Q2 2026, up 2.94% quarter-over-quarter from 0.4 in Q1 2026.
Analysis
Genmab A (GMAB) Debt Ratio (2022 - 2026) Analysis & Trends
Genmab A (GMAB) has reported Debt Ratio for 5 consecutive years, with 0.41 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Debt Ratio changed N/A year-over-year to 0.41; the trailing twelve-month figure through Jun 2026 stood at 0.41 (changed N/A YoY), and the FY2025 full-year result was 0.41, up 2787.82% from the prior year.
- Debt Ratio climbed to 0.41 in Q2 2026 per GMAB's latest filing, from 0.4 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.41 in Q2 2026 and bottomed at 0.02 in Q4 2024.
- Historically, Debt Ratio has averaged 0.22 across 5 years, with a median of 0.21 in 2026.
- The sharpest annual moves came in 2024 and 2025: Debt Ratio decreased 21.11% in 2024, then jumped 1819.07% in 2025.
- Over 5 years, Debt Ratio stood at 0.03 in 2022, then advanced by 3.91% to 0.03 in 2023, then fell by 21.11% to 0.02 in 2024, then surged by 1819.07% to 0.41 in 2025, then increased by 0.15% to 0.41 in 2026.
- According to Business Quant data, Debt Ratio over the past three periods registered 0.41, 0.4, and 0.41 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 0.66 |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | 0.58 |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 0.05 |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | 0.05 |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | - |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 0.25 |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | - |
| 10 | Genmab A | 2.23 Bn | 728.64 Mn | 1.07 Bn | 0.41 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.41 |
| Mar 31, 2026 | 0.40 |
| Dec 31, 2025 | 0.41 |
| Dec 31, 2024 | 0.02 |
| Dec 31, 2023 | 0.03 |
| Dec 31, 2022 | 0.03 |